[2009 Archive] [2008 Archive] [2007 Archive] [2006 Archive] [2005 Archive] [2004 Archive] [2003 Archive] [2009_Archive]
12/01/2003 --
Columbia Laboratories Grants Approval to Allow Shareholder to Increase Position to 19.9%
11/18/2003 --
Columbia Laboratories Appoints George W. Creasy, M.D. to Vice President, Clinical Research and Paul B. Schwartz to Executive Director, Licensing & Business Development
11/12/2003 --
Columbia Laboratories Initiates U.S. Study in Pregnant Women at High Risk of Preterm Delivery
Columbia Laboratories Reports 2003 Third Quarter Financial Results
11/07/2003 --
Columbia Laboratories to Hold Conference Call on Third Quarter 2003 Financial Results
10/30/2003 --
Columbia Labs Reports Successful Completion of Formulation Optimization for Desmopressin Buccal Tablet
10/20/2003 --
Columbia Laboratories to Webcast Presentation at Rodman & Renshaw Techvest Healthcare Conference
09/25/2003 --
Robert S. Mills Promoted to Senior Vice President and Chief Operating Officer of Columbia Laboratories
08/07/2003 --
Columbia Laboratories Reports 2003 Second Quarter Financial Results
08/01/2003 --
Columbia Laboratories to Hold Conference Call on Second Quarter 2003 Earnings Results Thursday August 7
07/24/2003 --
Columbia Laboratories Raises $26.3 Million through Sale of Common Stock
06/20/2003 --
U.S. FDA Approves STRIANT, a New Treatment Form for Men with a Deficiency or Absence of Testosterone
Conference Call Regarding FDA Approval of STRIANT (Testosterone Buccal System)
06/09/2003 --
COLUMBIA LABORATORIES ANNOUNCES MARKETING PARTNERSHIP WITH MIPHARM S.p.A. FOR STRIANT™ (TESTOSTERONE BUCCAL SYSTEM) MUCOADHESIVE IN ITALY
05/15/2003 --
Columbia Laboratories to Present at UBS Warburg Global Specialty Pharmaceuticals Conference
Fred Wilkinson Elected Chairman of Columbia Laboratories
05/14/2003 --
Columbia Laboratories Reports First Quarter 2003 Financial Results
05/06/2003 --
Columbia Laboratories to Host First Quarter 2003 Financial Results Conference Call
04/29/2003 --
Columbia Laboratories to Present at the Deutsche Bank Securities 28th Annual Health Care Conference
04/25/2003 --
Columbia Laboratories to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
04/15/2003 --
William Bologna to Step Down as Chairman of Columbia Laboratories
03/20/2003 --
Columbia Laboratories Commences Product Launch for Prochieve 4% (Progesterone Gel)
03/11/2003 --
Columbia Laboratories Reports Fourth Quarter and Year-End 2002 Financial Results
03/05/2003 --
Columbia Laboratories to Host Fourth Quarter 2002 Financial Results Conference Call